首页> 外文期刊>International journal of infectious diseases : >Prevalence of type-specific oncogenic human papillomavirus infection assessed by HPV E6/E7 mRNA among women with high-grade cervical lesions
【24h】

Prevalence of type-specific oncogenic human papillomavirus infection assessed by HPV E6/E7 mRNA among women with high-grade cervical lesions

机译:HPV E6 / E7 mRNA评估宫颈高级别病变女性中特定类型致癌性人乳头瘤病毒感染的患病率

获取原文
           

摘要

Objectives: Human papillomavirus (HPV) infection is a major cause of premalignant dysplasia and cervical cancer. There are no data on the prevalence of genotype-specific HPV infection assessed by HPV E6/E7 mRNA in women representative of the Korean population across a broad age range. Methods: A total of 630 women aged 17-90 years were enrolled in this study. ThinPrep liquid-based cytology samples were evaluated using the CervicGen HPV RT-qDx assay, which detects 16 high-risk (HR) HPV genotypes (set 1: HPV 16, 31, 33, 35, 52, and 58; set 2: HPV 18, 39, 45, 51, 59, and 68; and set 3: HPV 53, 56, 66, and 69). Results: The overall prevalence of HPV infection was 33.2% (n=209), and oncogenic high-risk HPV was detected in 75.9% (n=107) of 141 women with high-grade cervical lesions. HPV 16 was the most common HPV genotype among women with high-grade cervical lesions and histologically confirmed cervical intraepithelial neoplasia grade 2 and above (CIN2+) in the Republic of Korea (41.6%). Among women aged over 30 years, 182/329 (55%) had invasive cervical cancer and 135 (74%) of these were infected with oncogenic HR-HPV types (in particular 25% with HPV 16). Among patients diagnosed with CIN2+, the positivity rate of HR-HPV was the highest in women aged 40-49 years. Conclusions: These results suggest that the determination of specific HPV genotypes is very important for evaluating the potential impact of preventive measures, including the use of prophylactic vaccines, on reducing the burden of cervical cancer.
机译:目的:人乳头瘤病毒(HPV)感染是恶变前异常增生和宫颈癌的主要原因。目前尚无关于通过HPV E6 / E7 mRNA评估的朝鲜族妇女在广泛年龄范围内的基因型特异性HPV感染患病率的数据。方法:共有630名年龄在17-90岁的女性参加了这项研究。使用CervicGen HPV RT-qDx分析评估ThinPrep液基细胞学样品,该分析可检测16种高风险(HR)HPV基因型(组1:HPV 16、31、33、35、52和58;组2:HPV 18、39、45、51、59和68;第3组:HPV 53、56、66和69)。结果:HPV感染的总体患病率为33.2%(n = 209),在141例高度宫颈病变的女性中检出致癌高危HPV的比例为75.9%(n = 107)。在大韩民国,宫颈高级别病变且经组织学证实为2级及以上的宫颈上皮内瘤变(CIN2 +)的女性中,HPV 16是最常见的HPV基因型(41.6%)。在30岁以上的女性中,182/329(55%)患有浸润性宫颈癌,其中135(74%)被致癌的HR-HPV类型感染(特别是25%的HPV 16被感染)。在诊断为CIN2 +的患者中,HR-HPV阳性率在40-49岁的女性中最高。结论:这些结果表明,确定特定HPV基因型对于评估预防措施(包括使用预防性疫苗)对减轻子宫颈癌负担的潜在影响非常重要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号